Yingzi Liu Selected Research

Ovarian Neoplasms (Ovarian Cancer)

12/2021	Rs3802278 in 3'-UTR of SULF1 associated with platinum resistance and survival in Chinese epithelial ovarian cancer patients.
1/2021	Incorporating SULF1 polymorphisms in a pretreatment CT-based radiomic model for predicting platinum resistance in ovarian cancer treatment.
1/2020	The Novel Zinc Finger Protein 587B Gene, ZNF587B, Regulates Cell Proliferation and Metastasis in Ovarian Cancer Cells in vivo and in vitro.
1/2019	Loss of ZNF587B and SULF1 contributed to cisplatin resistance in ovarian cancer cell lines based on Genome-scale CRISPR/Cas9 screening.
6/2015	[eIF3a gene polymorphism and chemo-sensitivity to platinum-based drugs in ovarian cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingzi Liu Research Topics

Disease

12	Neoplasms (Cancer) 11/2023 - 02/2017
5	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 06/2015
4	Glioma (Gliomas) 01/2023 - 01/2020
3	Rosacea (Acne Rosacea) 01/2021 - 04/2019
2	COVID-19 01/2023 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2017
2	Ovarian Epithelial Carcinoma 12/2021 - 10/2017
1	Immune System Diseases (Immune Disorders) 11/2023
1	Obesity 11/2023
1	Asthma (Bronchial Asthma) 11/2023
1	Nevus (Nevi) 06/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Adenocarcinoma 11/2022
1	Lymphatic Metastasis 11/2022
1	Staphylococcal Infections 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Infections 01/2021
1	Inflammation (Inflammations) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Lung Neoplasms (Lung Cancer) 05/2018
1	Hyperoxia 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Osteoporosis 01/2018
1	Parkinsonian Disorders (Parkinsonism) 01/2018
1	Hemolysis 11/2017
1	Brain Neoplasms (Brain Tumor) 02/2017
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015
1	Carcinoma (Carcinomatosis) 08/2013
1	Endometrial Neoplasms (Endometrial Cancer) 08/2013
1	Carcinogenesis 08/2013
1	Human Influenza (Influenza) 01/2009

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2009
7	PlatinumIBA 12/2021 - 06/2015
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2022
2	VaccinesIBA 01/2023 - 01/2021
2	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2021
2	SulfatasesIBA 12/2021 - 01/2021
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2019
2	Messenger RNA (mRNA)IBA 04/2019 - 01/2018
1	bisphenol AIBA 11/2023
1	AntigensIBA 11/2023
1	LipopolysaccharidesIBA 11/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2023
1	OsteopontinIBA 06/2023
1	Biocompatible Materials (Biomaterials)IBA 01/2023
1	Histones (Histone)IBA 01/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2022
1	Estrogen ReceptorsIBA 11/2022
1	Estrogens (Estrogen)FDA Link 11/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2022
1	HhAntag691IBA 10/2022
1	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 01/2022
1	Flavin-Adenine Dinucleotide (FAD)IBA 01/2022
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2022
1	erastinIBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Toll-Like Receptor 4IBA 01/2021
1	CathelicidinsIBA 01/2021
1	Antimicrobial PeptidesIBA 01/2021
1	artemisinin (artemisinine)IBA 01/2020
1	ArtesunateIBA 01/2020
1	EnzymesIBA 01/2020
1	Sterol Regulatory Element Binding Protein 2IBA 01/2020
1	Mevalonic Acid (Mevalonate)IBA 01/2020
1	Long Noncoding RNAIBA 01/2020
1	ClaudinsIBA 04/2019
1	Protons (Proton)IBA 01/2019
1	alpha-hydroxyglutarateIBA 05/2018
1	vitexinIBA 01/2018
1	ManganeseIBA 01/2018
1	SodiumIBA 01/2018
1	LignansIBA 01/2018
1	AntioxidantsIBA 11/2017
1	1,1-diphenyl-2-picrylhydrazylIBA 11/2017
1	Free RadicalsIBA 11/2017
1	Stimuli Responsive PolymersIBA 03/2017
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 03/2017
1	DeuteriumIBA 02/2017
1	Peptide Initiation Factors (Initiation Factor)IBA 06/2015
1	MicroRNAs (MicroRNA)IBA 08/2013
1	Oxidoreductases (Dehydrogenase)IBA 01/2009
1	NucleoproteinsIBA 01/2009
1	Neuraminidase (Sialidase)IBA 01/2009
1	Adenosine Triphosphatases (ATPase)IBA 01/2009
1	Ion Channels (Ion Channel)IBA 01/2009
1	Inosine Monophosphate (IMP)IBA 01/2009
1	Hemagglutinins (Hemagglutinin)IBA 01/2009
1	Peptide Hydrolases (Proteases)FDA Link 01/2009
1	RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA 01/2009

Therapy/Procedure

3	Therapeutics 11/2022 - 01/2021
3	Drug Therapy (Chemotherapy) 12/2021 - 06/2015
1	Radiotherapy 01/2020
1	Electrodes (Electrode) 03/2017
1	Boron Neutron Capture Therapy 02/2017
1	Lasers (Laser) 06/2015